Finding major disease risk early enough to act
Most healthspan is won before disease appears. Early detection, precise biomarker monitoring and immune and inflammation management shift care from treatment to prevention.
What this stage covers
Cardiovascular and neurodegenerative prevention
Early detection and prevention of cardiovascular disease and neurodegenerative conditions such as Alzheimer's.
Early tumour risk assessment
Risk stratification and early signals that support timely clinical follow-up.
Immune enhancement and inflammation management
Managing chronic inflammation and supporting immune resilience with ageing.
Glycan-chemistry-based disease prediction
Glycomic signatures used as predictive markers of disease risk.
Peripheral blood testing and biomarker monitoring
Minimally invasive blood panels with precise, repeated biomarker tracking.
Who takes part
What it produces
Prevention data highlights where regenerative and cell-based interventions may be appropriate.
Explore chronic & major disease prevention
Join MR Longevity to find projects, collaborators and capital aligned with this focus.